A carregar...

Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis

BACKGROUND: The objective of this study is to compare the long-term cost-utility of imrecoxib and celecoxib for patients with osteoarthritis (OA) from the perspective of the Chinese healthcare system. METHODS: An economic model was built based on the model from the National Institute for Health and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Sun, Xueshan, Zhen, Xuemei, Hu, Xiaoqian, Li, Yuanyuan, Gu, Shuyan, Gu, Yuxuan, Zhao, Zixuan, Yang, Wei, Dong, Hengjin
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105807/
https://ncbi.nlm.nih.gov/pubmed/33987273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!